References
-
Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229–263 (2024).
-
Zhang, W. et al. Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma. Front. Immunol. 14, 1179742 (2023).
-
Hao, D. et al. The single-cell immunogenomic landscape of B and plasma cells in early-stage lung adenocarcinom. Cancer Discov. 12, 2626–2645 (2022).
-
Lin, Y. et al. Progress in single-cell RNA sequencing of lung adenocarcinoma. Zhongguo Fei Ai Za Zhi. 24, 434–440 (2021).
-
Hu, R. et al. ISR Inhibition reverses pancreatic β-cell failure in Wolfram syndrome models. Cell. Death Differ. 31, 322–334 (2024).
-
Koromilas, A. E. Roles of the translation initiation factor eIF2α serine 51 phosphorylation in cancer formation and treatment. Biochim. Biophys. Acta. 1849, 871–880 (2015).
-
Ghaddar, N. et al. The integrated stress response is tumorigenic and constitutes a therapeutic liability in KRAS-driven lung cancer. Nat. Commun. 12, 4651 (2021).
-
Albert, A. E. et al. Adaptive protein translation by the integrated stress response maintains the proliferative and migratory capacity of lung adenocarcinoma cells. Mol. Cancer Res. 17, 2343–2355 (2019).
-
Koromilas, A. E. The integrated stress response in the induction of mutant KRAS lung carcinogenesis: mechanistic insights and therapeutic implications. Bioessays 44, e2200026 (2022).
-
Rao, W. et al. A three-subtype prognostic classification based on base excision repair and oxidative stress genes in lung adenocarcinoma and its relationship with tumor microenvironment. Sci. Rep. 15, 16647 (2025).
-
Wan, L. et al. Identification of endoplasmic reticulum stress-related signature characterizes the tumor microenvironment and predicts prognosis in lung adenocarcinoma. Sci. Rep. 13, 19462 (2023).
-
Lin, L. et al. Integrated profiling of endoplasmic reticulum stress-related DERL3 in the prognostic and immune features of lung adenocarcinoma. Front. Immunol. 13, 906420 (2022).
-
Lior, C. et al. Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response. Cell. Rep. 43, 114236 (2024).
-
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
-
Wang, J. et al. PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma. Front. Immunol. 13, 1052692 (2022).
-
Gu, Z. Complex heatmap visualization. Imeta 1, e43 (2022).
-
Chen, H. & Boutros, P. C. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinform. 12, 35 (2011).
-
Wu, T. et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov. (Camb). 2, 100141 (2021).
-
Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457–462 (2016).
-
Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).
-
Liu, P., Xu, H., Shi, Y., Deng, L. & Chen, X. Potential molecular mechanisms of plantain in the treatment of gout and hyperuricemia based on network pharmacology. Evid Based Complement Alternat Med. 2020, 3023127 (2020).
-
Shi, Y. et al. Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy. Apoptosis 28, 1423–1435 (2023).
-
Li, Y., Lu, F. & Yin, Y. Applying logistic LASSO regression for the diagnosis of atypical Crohn’s disease. Sci. Rep. 12, 11340 (2022).
-
Li, D. & Lyu, G. Prognostic implications and therapeutic potential of MXD genes in gastric cancer. Curr. Med. Chem. (2025).
-
Moncrieff, J. et al. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol. Psychiatry. 28, 3243–3256 (2023).
-
Lin, Z. et al. Comprehensive analysis of copper-metabolism-related genes about prognosis and immune microenvironment in osteosarcoma. Sci. Rep. 13, 15059 (2023).
-
Mayakonda, A., Lin, D. C., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28, 1747–1756 (2018).
-
Dong, B. et al. Identification of a prognostic signature associated with the homeobox gene family for bladder cancer. Front. Mol. Biosci. 8, 688298 (2021).
-
Zheng, J. et al. Integrative analysis of multi-omics identified the prognostic biomarkers in acute myelogenous leukemia. Front. Oncol. 10, 591937 (2020).
-
Maeser, D., Gruener, R. F. & Huang, R. S. OncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 22, (2021).
-
Wang, L. et al. Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma. Front. Immunol. 13, 989286 (2022).
-
Chen, B., Khodadoust, M. S., Liu, C. L., Newman, A. M. & Alizadeh, A. A. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol. Biol. 1711, 243–259 (2018).
-
Yang, Y., Yi, X., Cai, Y., Zhang, Y. & Xu, Z. Immune-associated gene signatures and subtypes to predict the progression of atherosclerotic plaques based on machine learning. Front. Pharmacol. 13, 865624 (2022).
-
Møller, P. L. et al. Predicting the presence of coronary plaques featuring high-risk characteristics using polygenic risk scores and targeted proteomics in patients with suspected coronary artery disease. Genome Med. 16, 40 (2024).
-
Hu, F. F., Liu, C. J., Liu, L. L., Zhang, Q. & Guo, A. Y. Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response. Brief Bioinform. 22, (2021).
-
Xue, C. et al. Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes. Cancer Cell. Int. 22, 308 (2022).
-
Brinkman, E. K. & van Steensel, B. Rapid quantitative evaluation of CRISPR genome editing by TIDE and TIDER. Methods Mol. Biol.. 1961, 29–44 (2019).
-
Zhang, H., Meltzer, P. & Davis, S. RCircos: an R package for circos 2D track plots. BMC Bioinform. 14, 244 (2013).
-
Yu, G. et al. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products. Bioinformatics 26, 976–978 (2010).
-
He, Q. et al. Biochanin A protects against iron overload associated knee osteoarthritis via regulating iron levels and NRF2/System xc-/GPX4 axis. Biomed. Pharmacother. 157, 113915 (2023).
-
Cheng, F. et al. Shortened relative leukocyte telomere length is associated with prevalent and incident cardiovascular complications in type 2 diabetes: analysis from the Hong Kong diabetes register. Diabetes Care. 43, 2257–2265 (2020).
-
Chang, J. et al. Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma. J. Transl Med. 21, 191 (2023).
-
Yuan, S. et al. Smoking, alcohol consumption, and 24 Gastrointestinal diseases: Mendelian randomization analysis. Elife 12, (2023).
-
Scharping, N. E. et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45, 374–388 (2016).
-
Herbst, R. S., Morgensztern, D. & Boshoff, C. The biology and management of non-small cell lung cancer. Nature 553, 446–454 (2018).
-
Serveaux-Dancer, M. et al. Pathological implications of receptor for advanced glycation End-Product (AGER) gene polymorphism. Dis. Markers. 2019, 2067353 (2019).
-
Awan, U. N. et al. RAGE signalling contributes to oxidative stress and inflammation in knee osteoarthritis patients with metabolic syndrome. Clin. Exp. Rheumatol. 42, 2258–2264 (2024).
-
Sarang, S. S., Cahill, C. M. & Rogers, J. T. Gene expression analysis and validation of a novel biomarker signature for early-stage lung adenocarcinoma. Biomolecules. 15, (2025).
-
Yang, J. et al. Advanced glycation end products’ receptor DNA methylation associated with immune infiltration and prognosis of lung adenocarcinoma and lung squamous cell carcinoma. Genet. Res. 2023, 7129325 (2023).
-
Zhuang, G. D. et al. Huang-Lian-Jie-Du Decoction alleviates diabetic encephalopathy by regulating inflammation and pyroptosis via suppression of AGEs/RAGE/NF-κB pathways. J. Ethnopharmacol. 337, 118787 (2025).
-
Chu, X. et al. Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-κB-mediated inflammation by regulating the PI3K/AKT/Nrf2 signaling pathway in a free fatty acid-induced NAFLD spheroid model. Lipids Health Dis. 24, 55 (2025).
-
Alicea Pauneto, C. D. M. et al. Intra-tumoral hypoxia promotes CD8(+) T cell dysfunction via chronic activation of integrated stress response transcription factor ATF4. Immunity 58, 2489–2504e2488 (2025).
-
Qiao, Y. et al. High glucose stimulates tumorigenesis in hepatocellular carcinoma cells through AGER-dependent O-GlcNAcylation of c-Jun. Diabetes 65, 619–632 (2016).
-
Nagarajan, S., Rosenbaum, J. & Joks, R. The relationship between allergic Rhinitis, Asthma, and cardiovascular disease in the National Health Interview Surveys (NHIS), 1999–2018. J. Allergy Clin. Immunol. Pract. 12, 1509–1519e1504 (2024).
-
Zhang, N., Liao, H., Lin, Z. & Tang, Q. Insights into the role of glutathione peroxidase 3 in non-neoplastic diseases. Biomolecules. 14, (2024).
-
Zhang, X. et al. An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer. Int. J. Oncol. 36, 405–414 (2010).
-
Liu, R. et al. Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma. Front. Immunol. 14, 1304529 (2023).
-
Bramble, M. S. et al. Glutathione peroxidase 3 is a potential biomarker for Konzo. Nat. Commun. 15, 7811 (2024).
-
Liu, K., Jin, M., Xiao, L., Liu, H. & Wei, S. Distinct prognostic values of mRNA expression of glutathione peroxidases in non-small cell lung cancer. Cancer Manag Res. 10, 2997–3005 (2018).
-
Sharma, S. S. & Dixit, N. K. Somatotype of athletes and their performance. Int. J. Sports Med. 6, 161–162 (1985).
-
Zhang, G., Wang, X., Rothermel, B. A., Lavandero, S. & Wang, Z. V. The integrated stress response in ischemic diseases. Cell. Death Differ. 29, 750–757 (2022).
-
Lu, H. J., Koju, N. & Sheng, R. Mammalian integrated stress responses in stressed organelles and their functions. Acta Pharmacol. Sin. 45, 1095–1114 (2024).
-
Costa-Mattioli, M. & Walter, P. The integrated stress response: from mechanism to disease. Science. 368, (2020).
-
Nakagawa, T. & Ohta, K. Quercetin regulates the integrated stress response to improve memory. Int. J. Mol. Sci. 20, (2019).
-
Duan, Y. A. et al. Interrelationship between platelets and BUN in postmenopausal patients with coronary heart disease: findings of the NHANES from 2003 to 2016. Eur. Rev. Med. Pharmacol. Sci. 28, 327–335 (2024).
-
Wu, J. et al. MicroRNA-188 suppresses G1/S transition by targeting multiple cyclin/CDK complexes. Cell. Commun. Signal. 12, 66 (2014).
-
Qin, R. X. et al. Transcriptomic analysis reveals the potential biological mechanism of AIS and lung adenocarcinoma. Front. Neurol. 14, 1119160 (2023).
-
He, Q. et al. Smoking-induced CCNA2 expression promotes lung adenocarcinoma tumorigenesis by boosting AT2/AT2-like cell differentiation. Cancer Lett. 592, 216922 (2024).
-
Robles-Jimenez, L. E. et al. Worldwide traceability of antibiotic residues from livestock in wastewater and soil: A systematic review. Animals. 12, (2021).
-
Tan, X. D., Luo, C. F. & Liang, S. Y. Antihyperlipidemic drug rosuvastatin suppressed tumor progression and potentiated chemosensitivity by downregulating CCNA2 in lung adenocarcinoma. J. Chemother. 36, 662–674 (2024).
-
Willer, S. M. Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart. J. Physiol. 601, 3717–3737 (2023).
-
Olschewski, A. et al. TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications. Eur. Respir. J. 50, (2017).
-
Gu, J. et al. Decoding the mechanism of proanthocyanidins in central analgesia: redox regulation and KCNK3 Blockade. Exp. Mol. Med. 57, 567–583 (2025).
-
Lin, G. et al. KCNK3 inhibits proliferation and glucose metabolism of lung adenocarcinoma via activation of AMPK-TXNIP pathway. Cell. Death Discov. 8, 360 (2022).
-
Smoot, B. et al. Potassium channel candidate genes predict the development of secondary lymphedema following breast cancer surgery. Nurs. Res. 66, 85–94 (2017).
-
Smith, J., Tho, L. M., Xu, N. & Gillespie, D. A. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv. Cancer Res. 108, 73–112 (2010).
-
AACR Project GENIE. Powering precision medicine through an international consortium. Cancer Discov. 7, 818–831 (2017).
-
Tan, Z. et al. CHEK1: a hub gene related to poor prognosis for lung adenocarcinoma. Biomark. Med. 16, 83–100 (2022).
-
Xu, C. et al. Tailoring an intravenously injectable oncolytic virus for augmenting radiotherapy. Cell. Rep. Med. 6, 102078 (2025).
-
Ward, N. P. Cys-regulation: oxidized CHK1 controls cross-compartment circuit of chemoresistance. Trends Cancer. 9, 700–702 (2023).
-
You, J., Wang, X., Wang, J., Yuan, B. & Zhang, Y. DDX59 promotes DNA replication in lung adenocarcinoma. Cell. Death Discov. 3, 16095 (2017).
-
Hapke, G., Yin, M. B. & Rustum, Y. M. Targeting molecular signals in chk1 pathways as a new approach for overcoming drug resistance. Cancer Metastasis Rev. 20, 109–115 (2001).
-
Jin, M. et al. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis. Thorac. Cancer. 13, 1276–1288 (2022).
-
Yu, Y. et al. Advanced glycation end products receptor RAGE controls myocardial dysfunction and oxidative stress in high-fat fed mice by sustaining mitochondrial dynamics and autophagy-lysosome pathway. Free Radic Biol. Med. 112, 397–410 (2017).
-
Pei, J. et al. GPX3 and GSTT1 as biomarkers related to oxidative stress during renal ischemia reperfusion injuries and their relationship with immune infiltration. Front. Immunol. 14, 1136146 (2023).
-
An, B. C. et al. GPx3-mediated redox signaling arrests the cell cycle and acts as a tumor suppressor in lung cancer cell lines. PLoS One. 13, e0204170 (2018).
-
Rais, A., Husain, A., Hasan, G. M. & Hassan M. I. A review on regulation of cell cycle by extracellular matrix. Int. J. Biol. Macromol. 232, 123426 (2023).
-
Chapman, K. B. & Wolfner, M. F. Determination of male-specific gene expression in drosophila accessory glands. Dev. Biol. 126, 195–202 (1988).
-
Bard, J. A. M. et al. Structure and function of the 26S proteasome. Annu. Rev. Biochem. 87, 697–724 (2018).
-
Solomon, H. et al. Post-translational regulation of p53 function through 20S proteasome-mediated cleavage. Cell. Death Differ. 24, 2187–2198 (2017).
-
Enenkel, C., Kang, R. W., Wilfling, F. & Ernst, O. P. Intracellular localization of the proteasome in response to stress conditions. J. Biol. Chem. 298, 102083 (2022).
-
Fan, W. et al. m(6)A-Modified SNRPA controls alternative splicing of ERCC1 exon 8 to induce cisplatin resistance in lung adenocarcinoma. Adv. Sci. (Weinh). 11, e2404609 (2024).
-
Kaiser, A. M. et al. p53 governs an AT1 differentiation programme in lung cancer suppression. Nature 619, 851–859 (2023).
-
Shah, R. et al. Polarization of THP-1-Derived human M0 to M1 macrophages exposed to flavored E-Liquids. Toxics. 13, (2025).
-
Malik, J. A. & Agrewala, J. N. Morphine’s role in macrophage polarization: exploring M1 and M2 dynamics and disease susceptibility. J. Neuroimmunol. 400, 578534 (2025).
-
Cassetta, L. et al. Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets. Cancer Cell. 35, 588–602e510 (2019).
-
Fang, X. et al. Multi-omics analysis identified macrophages as key contributors to sex-related differences in ulcerative colitis. Front. Immunol. 16, 1569271 (2025).
-
Helmink, B. A. et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577, 549–555 (2020).
-
Xu, K. et al. B-cell signatures characterize the immune landscape and predict LUAD prognosis via the integration of scRNA-seq and bulk RNA-seq. Sci. Rep. 15, 5453 (2025).
-
Chen, C. et al. Isoliensinine exerts antitumor effects in lung adenocarcinoma by inhibiting APEX1-driven ROS production. Front. Pharmacol. 16, 1555802 (2025).
-
Shi, H. et al. KLF13 promotes ferroptosis and chemosensitivity in lung adenocarcinoma. BMC Biol. 23, 178 (2025).
